Loading…

NAMSA announced plans to acquire WuXi AppTec's medical device testing operations in the U.S., including facilities in Minnesota and Georgia. The acquisition expands NAMSA's portfolio of clinical research and testing solutions for medtech companies.
“We are extremely pleased to announce our agreement with WuXi AppTec, as it enables us to expand our portfolio of clinical research and testing solutions for clients.”medicaldesignandoutsourcing.com
Summarized from public sources; check the original articles before acting on it.